Postdoctoral Fellowship Awards
2019 (Cycle 30)
| Targeting pH Homeostasis as a Therapeutic Approach for Pancreatic Cancer | 2019 (Cycle 30) | $195,450 |
| Sanford Burnham Prebys Medical Discovery Institute | Cancer | |
| Defining the mechanism of dynamic matrix stiffening-driven lung cancer metastasis | 2019 (Cycle 30) | $193,320 |
| University of California, San Diego | Cancer | |
| A Human iPSC-based Platform to Unravel the Role of Nicotine in the Pathogenesis of Abdominal Aortic Aneurysms | 2019 (Cycle 30) | $178,440 |
| Stanford University | Cardiovascular and Cerebrovascular Disease | |
| The effect of combustible cigarettes and electronic cigarettes on oral Candida pathogenesis | 2019 (Cycle 30) | $187,116 |
| University of California, Los Angeles | Oral Disease and Dental Health | |
| miR-200 MicroRNAs in Lung cancer metastasis | 2019 (Cycle 30) | $191,832 |
| University of California, Berkeley | Cancer | |
| Maternal inhaled nicotine enhances endothelial nitric oxide synthase uncoupling leading to a hypertensive phenotype in offspring | 2019 (Cycle 30) | $187,831 |
| Loma Linda University | Cardiovascular and Cerebrovascular Disease | |
| Targeting the unique metabolic vulnerabilities of lung cancer | 2019 (Cycle 30) | $199,872 |
| University of California, San Diego | Cancer | |
| Effect of nicotine on the cardiac aging process | 2019 (Cycle 30) | $191,832 |
| University of California, San Diego | Cardiovascular and Cerebrovascular Disease | |
| Effects of Prenatal Nicotine and THC on Dopaminergic Function and Nicotine Intake During Adolescence | 2019 (Cycle 30) | $199,872 |
| University of California, Irvine | Neuroscience of Nicotine Addiction and Treatment | |
| Stem cell signals in the initiation and progression of lung cancer | 2019 (Cycle 30) | $137,550 |
| University of California, San Diego | Cancer | |
| Effects of long-term nicotine exposure on stem cell therapy | 2019 (Cycle 30) | $207,300 |
| Stanford University | Cardiovascular and Cerebrovascular Disease | |
| Multilayer investigation of resistance mechanisms to WEE1 inhibition in Small Cell Lung Cancer | 2019 (Cycle 30) | $207,300 |
| Stanford University | Cancer | |
2019 (Cycle 29)
| Targeting nuclear receptors for the treatment of Pancreatic cancer | 2019 (Cycle 29) | $180,996 |
| University of California, San Diego | Cancer | |
| Constructing a Lung Cancer Map of Drug Resistance States with Single-Cell Analysis | 2019 (Cycle 29) | $138,450 |
| Stanford University | Cancer | |
| Everyday smoking contexts and practices of bisexual young adults | 2019 (Cycle 29) | $135,392 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Implications of stress-induced LPAR4 expression in lung and pancreatic cancers | 2019 (Cycle 29) | $180,996 |
| University of California, San Diego | Cancer | |
| Effects of Smoking on Hematopoietic Stem Cell Dysfunction and Hematologic Cancers | 2019 (Cycle 29) | $122,958 |
| University of California, Irvine | Cancer | |
| Epigenetic mechanisms in the inflammatory oral lesion of smokers | 2019 (Cycle 29) | $198,036 |
| University of California, Los Angeles | Oral Disease and Dental Health | |
| Effects of cigarette smoke on inflammasome activation in oral cells | 2019 (Cycle 29) | $176,616 |
| University of the Pacific | Oral Disease and Dental Health | |
| Notch3 in Human Lung Adenocarcinoma Pathogenesis and Heterogeneity | 2019 (Cycle 29) | $176,982 |
| University of California, San Francisco | Cancer | |
| Functions of caspase-8 mutations in development of head and neck cancer and anti-tumor immunity | 2019 (Cycle 29) | $247,872 |
| University of California, San Francisco | Oral Disease and Dental Health | |
| At the Intersection of social inequity: Tobacco use disparities among diverse LGBTQ adolescents | 2019 (Cycle 29) | $213,864 |
| San Diego State University Research Foundation | Tobacco-Use Prevention and Cessation | |
| Analysis of bladder cancer precursor formation as a basis for early therapeutic intervention | 2019 (Cycle 29) | $193,320 |
| Stanford University | Cancer | |
| Investigating the Roles of Stromal AR in Prostate Cancer Progression | 2019 (Cycle 29) | $203,280 |
| University of California, Santa Cruz | Cancer | |
| Modeling Smoking Induced Cardiac Dysfunction in 3D Microtissues | 2019 (Cycle 29) | $128,086 |
| Stanford University | Cardiovascular and Cerebrovascular Disease | |
2019 (Cycle 28)
| Flavored tobacco initiation among youth and young adults | 2019 (Cycle 28) | $62,243 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Defining the Role of Hedgehog Signaling in Emphysema | 2019 (Cycle 28) | $180,996 |
| University of California, San Francisco | Pulmonary Disease | |
| Protein Engineering Aids Chimeric Antigen Receptor Design | 2019 (Cycle 28) | $173,676 |
| Beckman Research Institute of the City of Hope | Cancer | |
| The Influence of Social Media on Adolescents' E-Cig Use | 2019 (Cycle 28) | $117,143 |
| Stanford University | Tobacco-Use Prevention and Cessation | |
| HER3-biased Sec61 modulators for treatment of cancers | 2019 (Cycle 28) | $173,676 |
| University of California, San Francisco | Cancer | |
| Brd4 function in cardiac lineage commitment & morphogenesis | 2019 (Cycle 28) | $136,538 |
| University of California, San Francisco | Cardiovascular and Cerebrovascular Disease | |
| Large-scale analysis of tumor suppressors in lung cancer | 2019 (Cycle 28) | $173,676 |
| Stanford University | Cancer | |
| The Influence of Social Media on Adolescents' E-Cig Use | 2019 (Cycle 28) | $60,503 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Inflammatory State of Macrophages and COPD Exacerbation | 2019 (Cycle 28) | $177,972 |
| University of California, San Francisco | Pulmonary Disease | |
| Exosome Release and the Immune Response to Exercise in COPD | 2019 (Cycle 28) | $193,320 |
| LA Biomedical Research Institute at Harbor-UCLA Medical Center | Pulmonary Disease | |
2018 (Cycle 27)
| Shear Stress : a Master Regulator of the Endothelial Chromatin | 2018 (Cycle 27) | $223,884 |
| Stanford University | Cardiovascular and Cerebrovascular Disease | |
| Role of exosomes in rescuing Xerostomia in head and neck cancer | 2018 (Cycle 27) | $200,297 |
| Stanford University | Oral Disease and Dental Health | |
| E-cigarette smoking-induced cardiac injury in East Asian AL | 2018 (Cycle 27) | $209,484 |
| Stanford University | Not specified | |
| Genetic dissection of oncogenic Kras signaling in lung cancer | 2018 (Cycle 27) | $184,512 |
| Stanford University | Cancer | |
| Targeting Macrophages in the Cancer Stem Cell Niche to Beat Chemoresistance | 2018 (Cycle 27) | $222,407 |
| University of California, Los Angeles | Cancer | |
| The Action of Nicotine and Nicotine Cessation Drugs Inside Cells | 2018 (Cycle 27) | $182,184 |
| California Institute of Technology | Neuroscience of Nicotine Addiction and Treatment | |
| Studies on SWI/SNF in 3D chromatin structure with viral epis | 2018 (Cycle 27) | $212,207 |
| University of California, Davis | Cancer | |
2017 (Cycle 26)
| Predilection of CHRNA5 SNP to smoking-related cardiotoxicity | 2017 (Cycle 26) | $118,800 |
| Stanford University | Socio-cultural, Behavioral and Psychological | |
| Analysis of Circulating Tumor RNA for Early Detection of Lung Cancer | 2017 (Cycle 26) | $118,800 |
| Stanford University | Early Diagnosis of Tobacco-Related Cancer | |
| ELECTROCHEMICAL ANALYSIS of DNMT1 and miRNA AS BIOMARKERS OF LUNG CANCER | 2017 (Cycle 26) | $118,800 |
| California Institute of Technology | Early Diagnosis of Tobacco-Related Cancer | |
2016 (Cycle 25)
| TERT expression and its involvement in pancreatic regeneration and PDAC | 2016 (Cycle 25) | $118,800 |
| Stanford University | Early Diagnosis of Tobacco-Related Cancer | |
| miR-34/449 miRNAs in airway multiciliated cells | 2016 (Cycle 25) | $9,551 |
| University of California, Berkeley | Pulmonary Disease | |
| Differential softening of smokers in California | 2016 (Cycle 25) | $98,339 |
| University of California, San Francisco | Tobacco-Related Health Disparities | |
| A Differential Approach to Investigate Head and Neck Cancer | 2016 (Cycle 25) | $118,800 |
| J. David Gladstone Institutes | Early Diagnosis/Pathogenesis | |
| High-throughput systems to dissect Snail-driven malignancy | 2016 (Cycle 25) | $69,879 |
| University of California, Los Angeles | Early Diagnosis of Tobacco-Related Cancer | |
| Molecular mechanisms of smoking-associated lung cancer | 2016 (Cycle 25) | $118,449 |
| Salk Institute for Biological Studies | Early Diagnosis of Tobacco-Related Cancer | |
| Lateral septum circuitry underlying vulnerability to nicotine consumption | 2016 (Cycle 25) | $118,800 |
| University of California, San Diego | Neuroscience of Nicotine Addiction and Treatment | |
| Smartphone-based smoking cessation with young adults | 2016 (Cycle 25) | $63,073 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
2015 (Cycle 24)
| Cardiotoxicity Study of Tobacco Smoking Using hiPSC-CMs | 2015 (Cycle 24) | $145,800 |
| Stanford University | Early Diagnosis/Pathogenesis | |
| Molecular and Cellular Phenotyping of Second Hand Smoke-Related Asthma | 2015 (Cycle 24) | $47,769 |
| Stanford University | Environmental Exposure/Toxicology | |
| ROLE OF TOBACCO-RELATED TOXICANTS IN CARDIOVASCULAR DISEASE | 2015 (Cycle 24) | $145,800 |
| University of California, San Diego | Early Diagnosis/Pathogenesis | |
2014 (Cycle 23)
| Targeting phospho-MARCKS in smoke-mediated lung cancer | 2014 (Cycle 23) | $91,436 |
| University of California, Davis | Early Diagnosis/Pathogenesis | |
| Effects of varenicline in heavy drinking smokers | 2014 (Cycle 23) | $118,870 |
| University of California, Los Angeles | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Detection of tumor DNA in plasma: definitive early diagnosis | 2014 (Cycle 23) | $25,104 |
| Stanford University | Early Diagnosis/Pathogenesis | |
| Health Disparities: Tobacco Media and LGBT Tobacco Use | 2014 (Cycle 23) | $143,935 |
| University of California, San Diego | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Novel modulation of AMPA receptor activity by ly-6 proteins | 2014 (Cycle 23) | $40,668 |
| University of California, San Diego | Environmental Exposure/Toxicology | |
2013 (Cycle 22)
| Chromatin remodellers Brg1 and Baf60c in heart development | 2013 (Cycle 22) | $145,800 |
| J. David Gladstone Institutes | Early Diagnosis/Pathogenesis | |
| Exploring media to reduce LGBT tobacco use | 2013 (Cycle 22) | $32,343 |
| Stanford University | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Targeting Smyd3 methyltansferase for lung cancer therapy | 2013 (Cycle 22) | $101,422 |
| Stanford University | Early Diagnosis/Pathogenesis | |
| Adoption and Implementation of Campus Tobacco-free Policies | 2013 (Cycle 22) | $41,670 |
| University of California, San Francisco | Industry Influence/Policy | |
| Menstrual cycle effects on response inhibition in smoking | 2013 (Cycle 22) | $96,661 |
| University of Southern California | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Nicotine Dependence, Metabolism and Smoke Intake in Blacks | 2013 (Cycle 22) | $87,835 |
| University of California, San Francisco | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| The role of VTA glutamate afferents in nicotine addiction | 2013 (Cycle 22) | $145,681 |
| University of California, San Diego | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
2012 (Cycle 21)
| Alpha4beta2 nAChR upregulation in the perforant pathway | 2012 (Cycle 21) | $26,898 |
| California Institute of Technology | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Novel biomarkers and chemoprevention approaches for SCLC | 2012 (Cycle 21) | $127,052 |
| Stanford University | Early Diagnosis/Pathogenesis | |
| Nicotine replacement therapy in pregnancy: friend or foe? | 2012 (Cycle 21) | $98,506 |
| University of California, San Diego | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Proteomic Assessment of Heavy Metal Mixture Exposure | 2012 (Cycle 21) | $45,000 |
| University of California, Riverside | Environmental Exposure/Toxicology | |
| Metabolic stress & cell survival in lung cancer | 2012 (Cycle 21) | $89,208 |
| The Burnham Institute for Medical Research | Early Diagnosis/Pathogenesis | |
| NOVEL nAChR MODULATORS FOR TREATING NICOTINE ADDICTION | 2012 (Cycle 21) | $107,727 |
| University of California, San Diego | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| NOVEL nAChR MODULATORS FOR TREATING NICOTINE ADDICTION | 2012 (Cycle 21) | $27,273 |
| Scripps Research Institute | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Delivering Smoking Cessation to Young Adults in Bars | 2012 (Cycle 21) | $84,993 |
| University of California, San Francisco | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Effect of mGlu7 receptor manipulation on actions of nicotine | 2012 (Cycle 21) | $89,777 |
| University of California, San Diego | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
2011 (Cycle 20)
| Epigenetic effects of cigarette smoke on the infant airway | 2011 (Cycle 20) | $82,569 |
| University of California, Davis | Pulmonary Disease | |
| International Health Policy and Tobacco Control in CA | 2011 (Cycle 20) | $84,927 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| Activation of DDAH for the Treatment of Atherosclerosis | 2011 (Cycle 20) | $87,350 |
| Stanford University | Cardiovascular Disease | |
| Notch mediated mechanisms of mammalian cerebral angiogenesis | 2011 (Cycle 20) | $104,396 |
| University of California, San Francisco | Cardiovascular Disease | |
| Mapping the EphA Receptor Landscape in Lung Cancer | 2011 (Cycle 20) | $98,299 |
| The Burnham Institute for Medical Research | Cancer | |
| The Role of Alpha2 nAChR Subtypes in Nicotine Withdrawal | 2011 (Cycle 20) | $135,000 |
| University of California, Los Angeles | Nicotine Dependence | |
| Mechanisms of ephrin-B2 signaling mediating vasodilation | 2011 (Cycle 20) | $131,921 |
| University of California, San Francisco | Cardiovascular Disease | |
| Gene-modified Stromal Cell Therapy for Lung Cancer | 2011 (Cycle 20) | $60,498 |
| University of California, Los Angeles | Cancer | |
| Cigarette smoke and lung injury: mechanism of nSMase2 action | 2011 (Cycle 20) | $117,255 |
| University of California, Davis | Pulmonary Disease | |
| Identification of Harm Reduction Sidestream Smoke Toxicants | 2011 (Cycle 20) | $135,000 |
| University of California, Riverside | General Biomedical Science | |
| Delineating mechanisms of endothelial cytoprotection by APC | 2011 (Cycle 20) | $65,805 |
| University of California, San Diego | Cardiovascular Disease | |
2010 (Cycle 19)
| Cessation and Environmental Smoking among Korean Americans | 2010 (Cycle 19) | $161,060 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| AMPA Receptors and Extinction of Nicotine-Seeking Behavior | 2010 (Cycle 19) | $135,000 |
| University of California, San Diego | Nicotine Dependence | |
| Switching off a lung cancer oncogene using small molecules | 2010 (Cycle 19) | $135,000 |
| University of California, San Francisco | Cancer | |
| Enhancing Validity of a South Asian Tobacco Survey Module | 2010 (Cycle 19) | $89,999 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Reversible Covalent Kinase Inhibitors to Combat Metastasis | 2010 (Cycle 19) | $135,000 |
| University of California, San Francisco | Cancer | |
| Oncogenic Activation Mechanisms of Phosphoinositol-3-Kinase | 2010 (Cycle 19) | $135,000 |
| University of California, San Francisco | Cancer | |
| Inhibiting lung cancer with DNA-binding polyamides | 2010 (Cycle 19) | $44,500 |
| California Institute of Technology | Cancer | |
| O-GlcNAc Glycosylation in Lung Cancer | 2010 (Cycle 19) | $111,397 |
| California Institute of Technology | General Biomedical Science | |
| Nicotinic Control of Glutamate Synapse Formation | 2010 (Cycle 19) | $135,000 |
| University of California, San Diego | Nicotine Dependence | |
| Smoking-related lung repair and early stage lung cancer | 2010 (Cycle 19) | $135,000 |
| University of California, Los Angeles | Cancer | |
| Regulation of APC-mediated PAR1 signaling | 2010 (Cycle 19) | $135,000 |
| University of California, San Diego | Cardiovascular Disease | |
2009 (Cycle 18)
| Harnessing the immune system to fight lung cancer | 2009 (Cycle 18) | $117,637 |
| University of California, Los Angeles | Cancer | |
| Dose dependent effects of passive smoke on vascular function | 2009 (Cycle 18) | $41,588 |
| University of California, San Francisco | Cardiovascular Disease | |
| Patterns of Tobacco and Marijuana Use Among Young Adults | 2009 (Cycle 18) | $135,000 |
| University of California, San Francisco | Epidemiology | |
| Innate Immune Response to Head and Neck Cancer Stem Cells | 2009 (Cycle 18) | $134,999 |
| Stanford University | Cancer | |
| Evaluation of GABA in impulsivity and nicotine dependence | 2009 (Cycle 18) | $97,458 |
| University of California, San Diego | Nicotine Dependence | |
| Role of nicotine and nAChRs in L-dopa-induced dyskinesias. | 2009 (Cycle 18) | $87,963 |
| SRI International | Public Health, Public Policy, and Economics | |
| Acquired apoptotic resistance in 3D lung cancer spheroids | 2009 (Cycle 18) | $135,000 |
| University of California, San Francisco | Cancer | |
| Migrating cancer stem cells & early cancer development | 2009 (Cycle 18) | $90,000 |
| University of California, Los Angeles | Cancer | |
| Targeting vascular lesions in hypercholesterolemic zebrafish | 2009 (Cycle 18) | $134,500 |
| University of California, San Diego | Cardiovascular Disease | |
| Control of cellular self-digestion in lung tumorigenesis | 2009 (Cycle 18) | $135,000 |
| The Burnham Institute for Medical Research | Cancer | |
| Subcellular basis of nicotine-induced receptor upregulation | 2009 (Cycle 18) | $135,000 |
| California Institute of Technology | Nicotine Dependence | |
| Un-cooling Smoking Using Social Identity Theory | 2009 (Cycle 18) | $90,000 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| Pathological Angiogenesis and Nicotine: Intracellular Calcium | 2009 (Cycle 18) | $135,000 |
| Stanford University | Cardiovascular Disease | |
| The role of Wilm's tumor gene 1 in lung cancer | 2009 (Cycle 18) | $135,000 |
| Stanford University | Cancer | |
| Reactive oxygen species in fresh and aging SHS particles | 2009 (Cycle 18) | $132,137 |
| Lawrence Berkeley National Laboratory | General Biomedical Science | |
| Protein networks for nicotinic acetylcholine receptors | 2009 (Cycle 18) | $134,878 |
| University of California, San Diego | Nicotine Dependence | |
2008 (Cycle 17)
| Targeted Imaging and Therapy of Lung Cancer | 2008 (Cycle 17) | $72,144 |
| Stanford University | Cancer | |
| 16S rRNA PhyloChip Analysis of Bacterial Communities in COPD | 2008 (Cycle 17) | $75,000 |
| University of California, San Francisco | Pulmonary Disease | |
| Mechanisms of Tumor Suppressor in Lung Cancer Initiation | 2008 (Cycle 17) | $75,000 |
| University of California, Davis | Cancer | |
| Nicotinic Regulation of GABAergic Inhibition/Excitation | 2008 (Cycle 17) | $75,000 |
| University of California, San Diego | Nicotine Dependence | |
| Role of lineage-specific oncogene TITF1 in lung cancer | 2008 (Cycle 17) | $74,500 |
| Stanford University | Cancer | |
| Allosteric Protein Kinase Modulators via Disulfide Trapping | 2008 (Cycle 17) | $75,000 |
| University of California, San Francisco | General Biomedical Science | |
| Genomic Assay to Identify Targets of Anticancer Therapeutics | 2008 (Cycle 17) | $70,076 |
| Stanford University | Cancer | |
2007 (Cycle 16)
| Alpha4* Nicotinic Receptor in Dopaminergic System | 2007 (Cycle 16) | $75,000 |
| California Institute of Technology | Nicotine Dependence | |
| Targeting anti-apoptotic Bcl-2 family members in lung cancer | 2007 (Cycle 16) | $75,000 |
| The Burnham Institute for Medical Research | Cancer | |
| Synthesis of Apoptotic Spirooxindoles | 2007 (Cycle 16) | $75,000 |
| Beckman Research Institute of the City of Hope | General Biomedical Science | |
| Inhibition of MYC-activated gene expression by polyamides | 2007 (Cycle 16) | $71,330 |
| California Institute of Technology | General Biomedical Science | |
| The Smoking Abstinence Questionnaire | 2007 (Cycle 16) | $74,997 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Role of inflammation in lung carcinoma neovascularization | 2007 (Cycle 16) | $75,000 |
| University of California, San Diego | Cancer | |
| Mechanism of DNA break repair in germline cells | 2007 (Cycle 16) | $75,000 |
| University of California, Davis | Cancer | |
| Oxygen Transport Following Lung Transplantation in COPD | 2007 (Cycle 16) | $74,500 |
| University of California, San Diego | Pulmonary Disease | |
| Impact of Positive Mood on Self-Control Depletion in Smoking | 2007 (Cycle 16) | $63,340 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Effect of Oxidation on Rate of ApoA-I - HDL Exchange | 2007 (Cycle 16) | $75,000 |
| Children's Hospital Oakland Research Institute | Cardiovascular Disease | |
| Novel Cationic Polymers for RNAi Delivery in NSCLC Treatment | 2007 (Cycle 16) | $34,141 |
| University of California, Irvine | Cancer | |
2006 (Cycle 15)
| The molecular basis of apoE and LDL receptor interaction | 2006 (Cycle 15) | $75,000 |
| Children's Hospital Oakland Research Institute | Cardiovascular Disease | |
| Effect of tobacco toxins on human germ cell development | 2006 (Cycle 15) | $33,290 |
| University of California, San Francisco | General Biomedical Science | |
| How omega-3 fatty acids prevent or slow cancer | 2006 (Cycle 15) | $74,808 |
| The Burnham Institute for Medical Research | Cancer | |
| Effect of tobacco toxins on human germ cell development | 2006 (Cycle 15) | $40,204 |
| Stanford University | General Biomedical Science | |
| Nicotine recp mediated dopamine release and chronic nicotine | 2006 (Cycle 15) | $75,000 |
| The Parkinson's Institute | General Biomedical Science | |
| Development of Fluorescent Probes for Sensing DNA Mismatches | 2006 (Cycle 15) | $65,369 |
| California Institute of Technology | General Biomedical Science | |
| How smoke induces lung damage via oxidative stress | 2006 (Cycle 15) | $75,000 |
| University of California, Davis | Pulmonary Disease | |
| Pathways of how socioeconomic context affects teen smoking | 2006 (Cycle 15) | $75,000 |
| University of California, Los Angeles | Public Health, Public Policy, and Economics | |
| Nicotine Receptors: Role in Nicotine Addiction | 2006 (Cycle 15) | $20,748 |
| California Institute of Technology | Nicotine Dependence | |
| Effect of Sidestream Tobacco Smoke on Parkin Null Mice | 2006 (Cycle 15) | $48,256 |
| University of California, Los Angeles | Cancer | |
2005 (Cycle 14)
| Marketing low-tar cigarettes and new harm-reduced products | 2005 (Cycle 14) | $74,500 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| Integrin receptors and heart disease | 2005 (Cycle 14) | $35,323 |
| University of California, San Diego | Cardiovascular Disease | |
| Bupropion and nicotine dependence: behavior & neurochemisty | 2005 (Cycle 14) | $37,500 |
| Scripps Research Institute | Nicotine Dependence | |
| Effects of nicotine on hematopoietic stem cell migration | 2005 (Cycle 14) | $74,500 |
| La Jolla Institute for Molecular Medicine | General Biomedical Science | |
| Chemical synthesis of communesin B, a novel antineoplastic | 2005 (Cycle 14) | $74,403 |
| California Institute of Technology | General Biomedical Science | |
| Bupropion and nicotine dependence: behavior & neurochemisty | 2005 (Cycle 14) | $37,000 |
| University of California, San Diego | Nicotine Dependence | |
| Nicotine's effects on uterine artery contractillity | 2005 (Cycle 14) | $73,878 |
| Loma Linda University | Nicotine Dependence | |
| Role of p53-regulated sestrin genes in lung cancer | 2005 (Cycle 14) | $73,500 |
| University of California, San Diego | Cancer | |
| Effect of PDGF inhibition on angiogenesis in lung cancer | 2005 (Cycle 14) | $74,500 |
| University of California, San Francisco | Cancer | |
| Role of GL12 in oral mucosa maintenance and carcinogenesis | 2005 (Cycle 14) | $73,485 |
| University of California, San Francisco | Cancer | |
2004 (Cycle 13)
| Nicotine effects on gene expression and metaplasticity | 2004 (Cycle 13) | $74,500 |
| Stanford University | Nicotine Dependence | |
| Regulation of nicotinic signaling | 2004 (Cycle 13) | $20,499 |
| University of California, San Diego | Nicotine Dependence | |
| Tobacco oxidants, EGF receptor stability, and lung disease | 2004 (Cycle 13) | $75,000 |
| University of California, Davis | Pulmonary Disease | |
| Chronic CO exposure impairs the developing auditory system | 2004 (Cycle 13) | $75,000 |
| University of California, Los Angeles | General Biomedical Science | |
| Nicotinic receptors at GABAergic synapses in the hippocampus | 2004 (Cycle 13) | $75,000 |
| University of California, San Diego | Nicotine Dependence | |
| The role of platelets in atherogenesis in the mouse | 2004 (Cycle 13) | $34,769 |
| University of California, San Francisco | Cardiovascular Disease | |
| Regulation of epithelial cell polarity and lung disease | 2004 (Cycle 13) | $75,000 |
| University of California, San Francisco | Pulmonary Disease | |
2003 (Cycle 12)
| Individual and gender differences in nicotine sensitivity | 2003 (Cycle 12) | $69,495 |
| University of California, Irvine | Nicotine Dependence | |
| Tobacco use, home policy, and life events in at-risk women | 2003 (Cycle 12) | $75,386 |
| San Diego State University Research Foundation | Epidemiology | |
| COX-2-dependent modulation of survivin in lung cancer | 2003 (Cycle 12) | $69,500 |
| University of California, Los Angeles | Cancer | |
| IRAK-1 & active TGF-beta: Counter-regulators in emphysema? | 2003 (Cycle 12) | $69,000 |
| University of California, San Francisco | Pulmonary Disease | |
| Tobacco industry analysis of secondhand smoke | 2003 (Cycle 12) | $70,000 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| Triglyceride metabolism: Genetics, smoking and heart disease | 2003 (Cycle 12) | $75,438 |
| J. David Gladstone Institutes | Cardiovascular Disease | |
| Structure of CYP2A6: the principal nicotine oxidase | 2003 (Cycle 12) | $75,060 |
| Scripps Research Institute | General Biomedical Science | |
| Regulatory genes of nicotine adaptation in C.elegans | 2003 (Cycle 12) | $70,000 |
| University of California, San Diego | Nicotine Dependence | |
| Second Hand Smoke: Latino asthmatic children | 2003 (Cycle 12) | $75,506 |
| San Diego State University Research Foundation | Epidemiology | |
| Mechanism of TGF-a shedding in lung cancer development | 2003 (Cycle 12) | $69,600 |
| University of California, San Francisco | Cancer | |
| Focal adhesion kinase regulation of Cox-2 in lung cancer | 2003 (Cycle 12) | $74,520 |
| Scripps Research Institute | Cancer | |
2002 (Cycle 11)
| Regulation of integrin activation by calcineurin | 2002 (Cycle 11) | $68,437 |
| Scripps Research Institute | Cardiovascular Disease | |
| Multibehavioral changes for disease prevention among smokers | 2002 (Cycle 11) | $69,824 |
| University of California, San Francisco | Epidemiology | |
| Nicotinic receptors on hippocampal neurons | 2002 (Cycle 11) | $69,940 |
| University of California, San Diego | Nicotine Dependence | |
| Tobacco carcinogens influence Ah-receptor function | 2002 (Cycle 11) | $43,344 |
| University of California, San Diego | Cancer | |
| Efficacy of the nicotine patch in adolescents & young adults | 2002 (Cycle 11) | $69,800 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Effect of cigarette smoke and nicotine on taste processing | 2002 (Cycle 11) | $70,000 |
| University of California, Davis | Nicotine Dependence | |
| Total synthesis of cribrostatin 4, a potent anticancer agent | 2002 (Cycle 11) | $74,927 |
| California Institute of Technology | Cancer | |
| Neuroadaptations underlying nicotine dependence | 2002 (Cycle 11) | $60,379 |
| Scripps Research Institute | Nicotine Dependence | |
2001 (Cycle 10)
| Depression as a predictor of smoking treatment outcome | 2001 (Cycle 10) | $52,467 |
| University of California, San Francisco | Epidemiology | |
| Molecular targets for tobacco oxidants in lung cell death | 2001 (Cycle 10) | $70,000 |
| University of California, Davis | Pulmonary Disease | |
| Contributions of CNRs to nicotinic signaling | 2001 (Cycle 10) | $70,000 |
| University of California, San Diego | Nicotine Dependence | |
| ZIP kinase and lung cancer | 2001 (Cycle 10) | $65,854 |
| The Burnham Institute for Medical Research | Cancer | |
| PPARs in intestinal and colonic tumorigenesis | 2001 (Cycle 10) | $74,952 |
| Salk Institute for Biological Studies | Cancer | |
| Neuronal nicotinic receptor trafficking in nicotine addiction | 2001 (Cycle 10) | $71,664 |
| California Institute of Technology | Nicotine Dependence | |
| Functions of IRF-1 and Smad3 interaction in lung cancer | 2001 (Cycle 10) | $69,750 |
| University of California, San Francisco | Cancer | |
| Nicotine dependence & schizophrenia | 2001 (Cycle 10) | $75,600 |
| Scripps Research Institute | Nicotine Dependence | |
2000 (Cycle 9)
| Mitotic spindle checkpoint & chromosomal instability | 2000 (Cycle 9) | $69,500 |
| Ludwig Institute for Cancer Research | General Biomedical Science | |
| Siah-family proteins in lung cancer | 2000 (Cycle 9) | $74,560 |
| The Burnham Institute for Medical Research | Cancer | |
| Transcriptional regulation in normal and neoplastic lung | 2000 (Cycle 9) | $69,350 |
| University of California, San Diego | Cancer | |
| Thiol-aldehyde adducts and tobacco smoke toxicity | 2000 (Cycle 9) | $49,622 |
| University of California, Davis | Pulmonary Disease | |
| Cell-cell interact reg distrib of nic receptrs on neurons | 2000 (Cycle 9) | $29,754 |
| University of California, San Diego | Nicotine Dependence | |
1999 (Cycle 8)
| Oxidized lipids and programmed cell death in atherosclerosis | 1999 (Cycle 8) | $69,116 |
| University of California, San Diego | Cardiovascular Disease | |
| The role of chloride in tobacco-smoke-induced cancer | 1999 (Cycle 8) | $30,580 |
| University of California, San Francisco | Cancer | |
| Importance of Rce1 and Ras in tobacco-induced cancers | 1999 (Cycle 8) | $75,209 |
| J. David Gladstone Institutes | Cancer | |
| Effects of PSA content and formal features on smoking norms | 1999 (Cycle 8) | $44,284 |
| Stanford University | Public Health, Public Policy, and Economics | |
| Effect of tobacco smoke on nitric oxide synthesis | 1999 (Cycle 8) | $70,000 |
| University of California, Davis | Cardiovascular Disease | |
| Study of novel metastasis inhibitors in lung cancer | 1999 (Cycle 8) | $69,208 |
| University of California, San Diego | Cancer | |
| Dynamics of state tobacco control making | 1999 (Cycle 8) | $70,000 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| A model system for smoking-related damage to proteins | 1999 (Cycle 8) | $75,375 |
| J. David Gladstone Institutes | Cardiovascular Disease | |
| Membrane proteins and TGF-alpha/EGFR: a role in lung cancer? | 1999 (Cycle 8) | $40,436 |
| University of California, San Francisco | Cancer | |
1998 (Cycle 7)
| BAG-1, a unique gene involved in smoking-associated cancers | 1998 (Cycle 7) | $75,060 |
| The Burnham Institute for Medical Research | Cancer | |
| Functional significance of the protein CD40 in lung cancer | 1998 (Cycle 7) | $35,000 |
| University of California, San Diego | Cancer | |
| How are beneficial cholesterol transport proteins produced? | 1998 (Cycle 7) | $37,069 |
| J. David Gladstone Institutes | Cardiovascular Disease | |
| Dissecting signaling pathways to test cancer-killing agents | 1998 (Cycle 7) | $69,694 |
| University of California, San Diego | Cancer | |
| Structural determinants of alpha-toxin: nAChR interactions | 1998 (Cycle 7) | $70,000 |
| University of California, San Diego | Nicotine Dependence | |
| Boosting the immune response against lung cancer | 1998 (Cycle 7) | $70,000 |
| University of California, Los Angeles | Cancer | |
| A study of Bax, a gene involved in killing tumor cells | 1998 (Cycle 7) | $75,060 |
| The Burnham Institute for Medical Research | Cancer | |
| TGF-a: we need it, but too much is bad | 1998 (Cycle 7) | $69,967 |
| University of California, San Francisco | Cancer | |
| The role of nitric oxide in nicot induced muscle cell death | 1998 (Cycle 7) | $68,011 |
| The Parkinson's Institute | Nicotine Dependence | |
1997 (Cycle 6)
| Does nicotine alter intercellular communication pathways? | 1997 (Cycle 6) | $68,864 |
| University of California, San Diego | Cancer | |
| Analysis of a nicotine-related receptor binding site | 1997 (Cycle 6) | $69,218 |
| University of California, San Francisco | Nicotine Dependence | |
| Role of intracellular signals in tobacco-related disease | 1997 (Cycle 6) | $69,600 |
| University of California, San Diego | Cancer | |
| A novel therapeutic target for stroke | 1997 (Cycle 6) | $72,310 |
| The Burnham Institute for Medical Research | Cardiovascular Disease | |
| Current legal issues in tobacco | 1997 (Cycle 6) | $34,746 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
1995 (Cycle 4)
| Regulation of Nicotinic Receptors on Neurons by Muscle | 1995 (Cycle 4) | $37,783 |
| University of California, San Diego | Nicotine Dependence | |
| Growth Factor Receptor Activation by Papillomavirus Proteins | 1995 (Cycle 4) | $63,439 |
| University of California, San Diego | Cancer | |
| Function of Rb-interacting zinc-finger protein, "RIZ" | 1995 (Cycle 4) | $13,665 |
| Sidney Kimmel Cancer Center | Cancer | |
| Proteolytic Maturation of Ras & Yeast a-Factor | 1995 (Cycle 4) | $65,000 |
| University of California, Berkeley | Cancer | |
| Effects of Disturbed Flow on Endothelial Cell Function | 1995 (Cycle 4) | $52,345 |
| University of California, Los Angeles | Cardiovascular Disease | |
| Physiology of Diastolic Dysfunction during Transient Ischemia | 1995 (Cycle 4) | $30,000 |
| University of California, San Francisco | Cardiovascular Disease | |
| The Cellular Localization and Function of Cyclophilin B | 1995 (Cycle 4) | $60,775 |
| University of California, San Diego | General Biomedical Science | |
| Function of Rb-interacting zinc-finger protein, "RIZ" | 1995 (Cycle 4) | $32,400 |
| The Burnham Institute for Medical Research | Cancer | |
| Isolation of a Tumor Promoter Induced C-Fos Kinase | 1995 (Cycle 4) | $55,000 |
| University of California, San Diego | Cancer | |
| Nicotine Interactions with Central Stress Circuitry | 1995 (Cycle 4) | $69,120 |
| Salk Institute for Biological Studies | Nicotine Dependence | |
| Role in Associated Proteins in TGF-B Receptor Signalling | 1995 (Cycle 4) | $29,990 |
| University of California, San Francisco | Cancer | |
1994 (Cycle 3)
| Self-Presentation: Adolescent Cigarette Effects | 1994 (Cycle 3) | $18,400 |
| University of Southern California | Public Health, Public Policy, and Economics | |
| Biochemical and Functional Characterization of HIP-116 | 1994 (Cycle 3) | $75,600 |
| Salk Institute for Biological Studies | General Biomedical Science | |
| Tobacco Smoke Exposure-Induced Alt of Vasc Fibrinolytic Sys | 1994 (Cycle 3) | $30,469 |
| University of California, San Diego | Cardiovascular Disease | |
| Regulation of the cJun protein by phosphorylation | 1994 (Cycle 3) | $70,000 |
| University of California, San Diego | General Biomedical Science | |
| Protein Kinases: Unique Probes for the ATP Binding Site | 1994 (Cycle 3) | $69,411 |
| University of California, San Diego | General Biomedical Science | |
| Molecular Mechanisms of Brain Nicotinic Receptor Inactivation | 1994 (Cycle 3) | $42,567 |
| California Institute of Technology | Nicotine Dependence | |
| Signal Transduction by TGF-d Precursor During Transformation | 1994 (Cycle 3) | $69,110 |
| University of California, San Francisco | Cancer | |
| MDMI a Gene Involved in Yeast Mitochondrial Inheritance | 1994 (Cycle 3) | $70,000 |
| University of California, San Diego | Cancer | |
| DNA Damage in Germ & Somatic Cells of Smokers | 1994 (Cycle 3) | $70,000 |
| University of California, Berkeley | General Biomedical Science | |
| Retinoid X Receptors in Oncogenesis | 1994 (Cycle 3) | $75,600 |
| Salk Institute for Biological Studies | Cancer | |
| Isolation/Oncogene-activated cJun Kinase Linking Ras to AP-1 | 1994 (Cycle 3) | $53,750 |
| University of California, San Diego | Cancer | |
| The Mechanics and Regulation of Centromere Function | 1994 (Cycle 3) | $69,586 |
| University of California, Santa Barbara | General Biomedical Science | |
| Cell Cycle Regulation of Proliferation Genes | 1994 (Cycle 3) | $32,400 |
| California Institute of Technology | Cancer | |
1993 (Cycle 2)
| Mechanisms of Thrombin/Receptor Interaction | 1993 (Cycle 2) | $68,817 |
| University of California, San Francisco | Cardiovascular Disease | |
| Involvement of RAS and Krev-1 in Lung Cancer | 1993 (Cycle 2) | $50,552 |
| The Burnham Institute for Medical Research | Cancer | |
| Nicotine, Paraventricular Nuclei and Corticosteroids | 1993 (Cycle 2) | $58,408 |
| University of California, San Francisco | General Biomedical Science | |
| Protein Prenyltransferases Required for Ras Function | 1993 (Cycle 2) | $70,000 |
| University of California, Berkeley | General Biomedical Science | |
| Nicotine-induced Changes in Gene Expression | 1993 (Cycle 2) | $70,000 |
| University of California, San Diego | Nicotine Dependence | |
| Regulation of Tranformation by the Fos Gene | 1993 (Cycle 2) | $61,384 |
| Salk Institute for Biological Studies | General Biomedical Science | |
| Assessment of Teen Tobacco Use by Primary Care Physicians | 1993 (Cycle 2) | $70,000 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Role of Yeast CDC7 Gene in Initiation of DNA Replicaton | 1993 (Cycle 2) | $44,906 |
| California Institute of Technology | General Biomedical Science | |
| Post-Translational Processing of Ras and Yeast a-Factor | 1993 (Cycle 2) | $70,000 |
| University of California, Berkeley | General Biomedical Science | |
| Regulation of CO2 Transport in Circulatory & Respiratory ... | 1993 (Cycle 2) | $75,600 |
| LA Biomedical Research Institute at Harbor-UCLA Medical Center | Cardiovascular Disease | |
| Neuronal ACh Receptors: Candidates for Mediating Addiction | 1993 (Cycle 2) | $66,994 |
| University of California, San Diego | Nicotine Dependence | |
| Homeobox Genes Hematopoiesis and Leukemogenesis | 1993 (Cycle 2) | $70,000 |
| University of California, Los Angeles | Cancer | |
| Ras Prenylation, Cholesterol Biosynthesis and Lung Cancer | 1993 (Cycle 2) | $49,960 |
| The Burnham Institute for Medical Research | Cancer | |
| Direct Effect of Nicotine on the Early Outward K Channel | 1993 (Cycle 2) | $75,588 |
| Northern California Institute for Research & Education | Pulmonary Disease | |
| Probing the Nucleotide Binding Site of Protein Kinases | 1993 (Cycle 2) | $41,146 |
| University of California, San Diego | General Biomedical Science | |
1992 (Cycle 1)
| Analysis of RAS Mutations in the Canine Smoking Model | 1992 (Cycle 1) | $70,000 |
| University of California, Davis | Cancer | |
| Cigarette Smoking Alterations in Thrombolytic Parameters | 1992 (Cycle 1) | $70,000 |
| University of California, San Diego | Cardiovascular Disease | |
| IL-1 & PDGF: mRNA & Protein in Prodution by Alveolar Macro | 1992 (Cycle 1) | $56,204 |
| University of California, San Diego | Pulmonary Disease | |
| Acute & Chronic Effects of Tobacco & Non-tobacco Smoking | 1992 (Cycle 1) | $27,491 |
| University of California, Los Angeles | Pulmonary Disease | |
| Molecular Mechanism of Retinoic Acid Action | 1992 (Cycle 1) | $75,600 |
| The Burnham Institute for Medical Research | General Biomedical Science | |
| Molecular Studies of NNK-Induced Lung Tumors in Hamsters | 1992 (Cycle 1) | $35,000 |
| University of California, Davis | Cancer | |
| Role of Jun Family of Proto-Oncogenes in Lung Cancer | 1992 (Cycle 1) | $68,400 |
| University of California, San Diego | Cancer | |
| Lung Reflexes & Afferent Properties in Health and Disease | 1992 (Cycle 1) | $70,000 |
| University of California, Davis | Pulmonary Disease | |
| Nicotine Effects on Enodthelial Cell Growth & Function | 1992 (Cycle 1) | $69,038 |
| University of California, Davis | Cardiovascular Disease | |
| Effects of Cigarette Smoke in Rat Pulmonary Arteries | 1992 (Cycle 1) | $68,650 |
| University of California, San Diego | Pulmonary Disease | |
| Drug Resistance During Induction Chemotherapy for Lung Cancer | 1992 (Cycle 1) | $31,874 |
| Stanford University | Cancer | |
| Glutathione Transferase in Lung Cancer: Transfection Studies | 1992 (Cycle 1) | $67,732 |
| Stanford University | Cancer | |
| Influence of Cigarette Smoke on Neurogenic Inflammation | 1992 (Cycle 1) | $57,180 |
| University of California, San Francisco | General Biomedical Science | |
| Endothelial Barrier Injury by Tobacco Smoke | 1992 (Cycle 1) | $60,945 |
| University of California, Davis | Cardiovascular Disease | |
| Smoking & Lipoprotein-Based Mechanisms of Atherogenesis | 1992 (Cycle 1) | $69,999 |
| University of California, San Francisco | Cardiovascular Disease | |
| Pulmonary Epithelial Injury by Tobacco Smoke in Vitro | 1992 (Cycle 1) | $70,616 |
| University of California, Davis | Pulmonary Disease | |
| Effects of Cigarettes & Carbon Monixide in Exercise in COP | 1992 (Cycle 1) | $75,247 |
| LA Biomedical Research Institute at Harbor-UCLA Medical Center | Pulmonary Disease | |
| Molecular Dynamics of Acetylcholinesterase Mutants | 1992 (Cycle 1) | $70,000 |
| University of California, San Diego | Nicotine Dependence | |
| Acute & Chronic Nicotine Treatment on Gastric Ulceration | 1992 (Cycle 1) | $70,000 |
| University of California, Los Angeles | General Biomedical Science | |
| Leukotriene A4 Hydrolase Secretion by Airway Epithelia | 1992 (Cycle 1) | $70,156 |
| University of California, San Diego | Pulmonary Disease | |
| Health Services Research | 1992 (Cycle 1) | $53,118 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |